drugset / Trial / NCT03393117
Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction
RandomizedParallel-groupSingle-blindSupportive care
Summary
The purpose of this study is to determine the most effective way to control post-operative breast pain for patients undergoing a unilateral, immediate breast reconstruction.
Timeline
- Start
- 2018-03-30
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |
| Background | Hydromorphone | Other / unclassified | — | — |
| Background | Morphine | Other / unclassified | — | — |